Tumor Growth Rate in Spinal Giant Cell Tumors of Bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study-Reference-Cited by-同舟云学术

Tumor Growth Rate in Spinal Giant Cell Tumors of Bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study

Published:2022-11-21 Issue:3 Volume:92 Page:524-537
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Zheng Bo-Wen,Zheng Bo-Yv,Niu Hua-Qing,Yang Yi-Fan,Zhu Guo-Qiang,Li Jing,Zhang Tao-Lan,Zou Ming-Xiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference33 articles.

1. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone;He;Cell Death Dis.,2021

2. Effect of adjuvant chemotherapy on localized malignant giant cell tumor of bone: a systematic review;Morii;Cancers (Basel).,2021

3. State of the art and new concepts in giant cell tumor of bone: imaging features and tumor characteristics;Parmeggiani;Cancers (Basel).,2021

4. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone;Rutkowski;Ann Surg Oncol.,2015

5. Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review;Ma;Eur Spine J.,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic and prognostic characteristics of tumor budding‐like in giant cell tumor of bone;Cancer;2024-09-06

2. Letter to the Editor Regarding “Preoperative Ocular Symptoms Predict Acute Glaucoma after Carotid Revascularization: An Analysis of Combined Single-Center Data and a Systematic Review”;World Neurosurgery;2024-09

3. Lymphocyte Infiltration Score and Spatial Characteristics Refined the Prognosis and Denosumab Treatment Responsiveness Indicators for Giant Cell Tumor of Bone;JCO Precision Oncology;2024-08

4. The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment;Journal of Orthopaedic Surgery and Research;2024-07-15

5. Letter to the editor regarding “The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature” by Humaid et al.;The Spine Journal;2024-07